India, July 14 -- image credit- freepik

Bengaluru-based OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formycon AG, an independent biosimilar developer headquartered in Munich, have announced a strategic manufacturing partnership for biosimilars.

Under the partnership, OneSource will serve as a strategic manufacturing partner for Formycon and provide integrated Drug Substance (DS) and Drug Product (DP) manufacturing capabilities from its state-of-the-art biologics' facility in Bangalore.

The collaboration brings together Formycon's Biosimilar development excellence with OneSource's end-to-end biologics manufacturing expertise to support Formycon's biosimilar programs for global markets.

The partnership reflect...